DK0010272202
DK0010272202
Genmab A/S
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 150.34B EUR | 110.28B EUR | 105.16B EUR | 124.86B EUR |
Enterprise Value | 149.73B EUR | 114.05B EUR | 108.99B EUR | 128.57B EUR |
Valuation Multiples | ||||
Trailing P/E | 30.16x | 139.95x | 128.09x | 162.58x |
Forward P/E | 22.34x | -- | -- | -- |
Price to Sales | 36.39x | 26.7x | 26.96x | 41.55x |
Price to Book | 3.69x | 18.51x | 18.51x | 21.35x |
EV/Revenue | 36.25x | 27.61x | 27.94x | 42.79x |
EV/EBITDA | 108.74x | 73.2x | 73.15x | 105.22x |
Price to FCF (P/FCF) | 172.68x | 127.05x | 120.6x | 142.86x |
EV/FCF | 171.98x | 131.39x | 124.99x | 147.11x |
FCF Yield | 0.58% | 0.79% | 0.83% | 0.7% |